Results 61 to 70 of about 11,406 (189)

A comparative study between the diagnostic performance of contrast-enhanced digital mammography and dynamic contrast-enhanced MRI in invasive lobular carcinoma of the breast

The Egyptian Journal of Radiology and Nuclear Medicine
Background Invasive lobular carcinoma is the second most prevalent histological subtype of breast cancer after invasive duct carcinoma, with a reported increased incidence in the last two decades.
Sherihan Fakhry, Rasha Mohamed Kamal, Omnia Mokhtar Nada, Amira Emad Abo El Enien Mohamed, Mennatallah Mohamed Hanafy   +4 more
doaj   +1 more source

Bilateral Breast Gradient Insert Prototype for Strong Diffusion Encoding at 3 T

Magnetic Resonance in Medicine, Volume 97, Issue 1, Page 414-424, January 2027.
ABSTRACT Purpose Diffusion MRI has shown promise for breast cancer screening, lesion characterization, and treatment response monitoring without contrast agents, but further translation is constrained by the gradient performance of conventional systems.
Gerrit Cornelis Arends, Edwin Versteeg, Feng Jia, Dennis W. J. Klomp, Maxim Zaitsev, Sebastian Littin, Chantal M. W. Tax   +6 more
wiley   +1 more source

Identification of a Circular RNA as a Potential Diagnostic and Prognostic Biomarker in Breast Cancer Through Integrated Bioinformatic and Experimental Analyses

Analytical Science Advances, Volume 7, Issue 2, December 2026.
Forty circular RNAs were found to be significantly dysregulated in microarray datasets. Expression levels of hsa_circ_0000231 were significantly upregulated in breast cancer (BC) tissues, while hsa_circ_0011385 exhibited no significant difference in expression levels. This study also revealed that hsa_circ_0000231/hsa‐miR‐5683/CCNB1 regulatory axis may
MohamadReza Hashemi, Pejman Morovat, Azin Khoshghiafeh, Novin Nikbakhsh, Mohamadreza Ahmadifard   +4 more
wiley   +1 more source

The Evolution of Breast Cancer Detection: A Review of Imaging, Machine Learning, and Multimodal Strategies

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Breast cancer is still a serious problem in the world arena, where its early and prompt detection is the most important factor in improving patient prognosis and survival. The use of traditional diagnostic techniques, such as imaging (e.g., mammography and ultrasound) and subsequent histopathological examination, is the mainstay, which ...
Likhon Chandra Sarkar, Farida Siddiqi Prity, Farhad Hussain, Anup Talukder, Mirza Raquib, Sharmina Rahman, MD Jiabul Hoque   +6 more
wiley   +1 more source

Big Data in Cancer Genomics: Computational Foundations and Emerging Pathways for Precision Oncology

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT This review aims to explore the computational foundations of big data in cancer genomics and examine emerging pathways that support precision oncology and personalized cancer care. A narrative review approach was adopted to synthesize evidence from PubMed, Scopus, Web of Science, and IEEE Xplore.
Nur Vanu, Nur Mohammad, Fahad Ahmed, Towsif Alam, Koushik Saha, Durga Shahi, Adib Hossain, Mia Md. Tofayel Gonee Manik, Mst. Rina Parvin   +8 more
wiley   +1 more source

De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer

International Journal of Cancer, Volume 159, Issue 10, Page 2393-2402, 15 November 2026.
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley   +1 more source

Potential Association of BRCA Mutation and Lymphocytic Lobulitis

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Lymphocytic lobulitis (LL) is a rare fibroinflammatory breast lesion historically associated with long‐standing Type 1 diabetes mellitus and autoimmune conditions. Recent evidence suggests possible links between LL and hereditary breast cancer syndromes, particularly BRCA mutations. We present the case of a BRCA1 mutation carrier who developed
Parul Garg, Sena Park, Femi E. Ayeni, Senarath Edirimanne   +3 more
wiley   +1 more source

Hematological Profiles and Serum Cytokine Levels in Patients With Breast Cancer in Low‐ and Middle‐Income Countries: A Systematic Review and Meta‐Analysis of Current Evidence

Health Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aim Breast cancer is a leading cause of morbidity and mortality in Low‐ and Middle‐Income Countries (LMICs). Hematological and inflammatory markers offer accessible, low‐cost tools for patient assessment; hence, this study synthesized evidence on hematological parameters and serum cytokine levels in breast cancer patients from ...
Richard Vikpebah Duneeh, Otchere Addai‐Mensah, Benedict Sackey, Ernest Adankwah, Edward Yaw Afriyie, Veronica Agyemang, Precious Kwablah Kwadzokpui, Emmanuel Ativi, Mercy Adzo Klugah, Francis Agyei Amponsah, Kenneth Ablordey   +10 more
wiley   +1 more source

Breast neuroendocrine neoplasms — characteristics in contrast-enhanced mammography

Endokrynologia Polska
INTRODUCTION: Neuroendocrine neoplasms of the breast (Br-NENs) constitute a heterogeneous group of rare tumors, whose number may be underestimated. Our study aims to evaluate and compare the analysis of the radiological features of Br-NEN and carcinomas ...
Agnieszka Niewiadomska, Anna Grażyńska, Violetta Rosiek, Mateusz Winder, Joanna Szczudło-Chraścina, Michał Hrapkowicz, Anna Barczyk-Gutkowska, Aleksandra Kuźbińska, Katarzyna Steinhof-Radwańska   +8 more
doaj   +1 more source

Application of MR Cytometry in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparative Study

Journal of Magnetic Resonance Imaging, Volume 64, Issue 5, Page 1346-1360, November 2026.
ABSTRACT Background MR cytometry imaging is developed to characterize in vivo microstructures. Its clinical value in predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer remains unknown. Purpose To implement MR cytometry to predict pCR for breast cancer and compare the performance of different ...
Jie Ding, Diwei Shi, Shiyun Sun, Jinlong Zheng, Wentao Yang, Caixia Fu, Dazhi Chen, Junzhong Xu, Hua Guo, Chao You, Yajia Gu   +10 more
wiley   +1 more source